Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ventura Cannabis and Wellness Corp CVHIF

Healthcare Drug Manufacturers - Specialty & Generic
Ventura Cannabis and Wellness Corp is a vertically integrated, California-based products cannabis company. The company is currently building out its distribution channel through revenue-sharing agreements with owner-operator of cannabis dispensaries to ensure it's products get premium shelf space. The Company plans to target four segments in the U.S. cannabis and CBD market with products suited to their needs: senior citizens, upwardly mobile middle-aged female professionals, upwardly mobile middle-aged male professionals and individuals suffering from addiction.


GREY:CVHIF - Post by User

Ventura Cannabis and Wellness Corp
Bullboard Posts
User Avatar Image
(0)
•••
Comment by FixedIncome12on Jun 29, 2018 1:56pm
94 Views
Post# 28252723

RE:I really dont like the whole revenue recognition for Q4

RE:I really dont like the whole revenue recognition for Q4Shifting away from core business, reducing revenues and issuing terrible NR undermining the stock was a great mistake. They should of focused on growing revenues and promoting the IMD exclusion and opioid hype... but you get mistakes like this when you have a young marketing blazer cool guy with no experience running the co IMO. Whaaaaatever glta
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities